Hu Qihui, Li Jiaxing, Wang Jixing, Chen Cong, Tao Rui
Bishan Hospital of Chongqing, Bishan Hospital of Chongqing Medical University, Chongqing, China.
J Egypt Natl Canc Inst. 2025 Jun 16;37(1):26. doi: 10.1186/s43046-025-00285-z.
Hepatocellular carcinoma during pregnancy is rare and poses significant potential risks to both the pregnant individual and the fetus. Here, we report a case of hepatocellular carcinoma during pregnancy. The 28-week gestational is a critical point of fetal maturation. A literature review revealed no similar case with survival exceeding 2 years, following resection of a large hepatocellular carcinoma diagnosed in late-stage pregnancy. This article may contribute to future research aimed at extending the survival time of patients with hepatocellular carcinoma diagnosed in late pregnancy.
A 33-year-old pregnant woman was diagnosed with hepatocellular carcinoma at 34 weeks of pregnancy. A cesarean section was performed at 34 weeks of pregnancy. Under general anesthesia, a right lobectomy of the liver was conducted after 15 days. The patient received continuous support from the clinical psychology team throughout the entire perioperative period. The postoperative recovery was smooth, and the patient was discharged without any significant complications. Approximately 2 years post-surgery, follow-up indicated that the patient remained alive and in good health.
The physiological changes associated with pregnancy can promote rapid tumor growth, leading to poor prognoses. Expert decision-making should be guided by the growth and maturation status of the fetus in relation to hepatocellular carcinoma development. For patients in the late stage of pregnancy, timely termination of pregnancy and tumor resection surgery, along with obtaining assistance from the clinical psychology team during the perioperative period, followed by post-discharge treatment with a combination of Sintilimab and Lenvatinib, constitutes an effective strategy for prolonging patient survival.
妊娠期间的肝细胞癌较为罕见,对孕妇和胎儿均构成重大潜在风险。在此,我们报告一例妊娠期间的肝细胞癌病例。妊娠28周是胎儿成熟的关键点。文献综述显示,对于妊娠晚期诊断出的大型肝细胞癌进行切除后,尚无存活超过2年的类似病例。本文可能有助于未来旨在延长妊娠晚期诊断出的肝细胞癌患者生存时间的研究。
一名33岁孕妇在妊娠34周时被诊断为肝细胞癌。在妊娠34周时进行了剖宫产。在全身麻醉下,15天后进行了肝右叶切除术。在整个围手术期,患者一直得到临床心理团队的持续支持。术后恢复顺利,患者出院时无任何重大并发症。术后约2年的随访表明,患者仍然存活且身体健康。
与妊娠相关的生理变化可促进肿瘤快速生长,导致预后不良。专家决策应以胎儿的生长和成熟状态与肝细胞癌发展的关系为指导。对于妊娠晚期的患者,及时终止妊娠和进行肿瘤切除手术,同时在围手术期获得临床心理团队的协助,随后出院后使用信迪利单抗和仑伐替尼联合治疗,是延长患者生存的有效策略。